🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Getting to the source of inequity in healthcare means getting to the source of inequity in society. This is a good start. fiercehealthcare.com/providers/kais…

Your Money or Your Life — The High Cost of #Cancer Drugs under Medicare Part D. nejm.org/doi/10.1056/NE… NEJM Stacie Dusetzina Fumiko Ladd Chino, MD, FASCO Yousuf Zafar, MD MHS #FinancialToxicity #PallOnc #HealthCare

It should go without saying, but it evidently can’t be said enough: good science communication matters. We are failing over and over and over again.

US spends more on cancer than any other country--by far. But cancer mortality? Just below median   We're missing something (emphasis on costly Rx & not on prevention/Dx?). Let's keep this in mind at #ASCO22   Great work by Cary Gross Yale COPPER Center jamanetwork.com/journals/jama-…

So proud of Dr ⁦@NarjustDumaMD⁩’s well earned place on this ⁦The Cancer Letter⁩ timeline on the evolution of ASCO annual meetings. Her #asco18 work on #genderEquity was essential at exposing what we can and should improve. cancerletter.com/in-the-archive…

Fun The Cancer Letter article on memories from 57yrs of ASCO (& thx for kind words, Fumiko Ladd Chino, MD, FASCO!) #MyFirstASCO: I was a resident standing by a lonely HSR poster, watching in awe as Jane Weeks presented, wondering if I’d ever get to do that! #ASCO22 cancerletter.com/cancer-history…

I cannot say enough about how proud I am of Fumiko Ladd Chino, MD, FASCO!! Then add Family Reach into the mix, and I’m swooning. #ASCO22

Tonight, I’m seeing HAIM in downtown Chicago! Tomorrow, looking forward to seeing old friends and new data at #ASCO22

Outstanding discussion by Dr. Cremolini of #mCRC PARADIGM trial. Do you agree with her treatment algorithm of FOLFOXIRI-bev for pts with KRAS-MT left-sided tumors? #ASCO2022

You know it’s big news when my mom in Ohio called me about this study. Congratulations to Andrea Cercek and team for a huge result for the benefit of our patients #ASCO22

Pashtoon Kasi MD, MS ASCO OncoAlert Ryan Huey, MD, MS Gabriel Brooks Jeremy Jones Manish A. Shah Ben Westphalen Andrea Cercek Anup Kasi MD MPH Manju George MVSc PhD Rectal Cancer Survivor Mike Thompson, MD, PhD, FASCO In her PARADIGM plenary discussion Chiara Cremolini (who is OWNING #ASCO22 podiums by the way) observed a ~3.5 month *loss* of median OS with bev first in 1st line L-sided ras/braf wt, MSS colon cancer

40% of Black patients say no one mentioned clinical trials to them. >90% say they want information on trials. This is shameful. We, as a community, need to do SO MUCH BETTER. Tigerlily Foundation #bcsm #clinicaltrials #ASCO22 OncoAlert

Deciding between adjuvant therapy yes/no for stage II #coloncancer? Check out Gabriel Brooks great summary. I would only add this: patient preference plays a role, of course #ASCO22

Scientists NEED to become better communicators. Proud of this manuscript highlighting HOW to present your research to diverse audiences, WHY it matters, and some Do's & Don'ts. With: Drs Aaron E. Carroll Stacie Dusetzina Yousuf Zafar, MD MHS & Ms. Margot Sanger-Katz in JNCI academic.oup.com/jncimono/artic…

LOVE this: "Looking for an actually concise explanation of a half-century’s worth of research and arguments about health care spending in the U.S.?" Well, here it is in one ppt. Thanks, Bob Herman STAT statnews.com/2022/10/03/get… cc: Stacie Dusetzina @StephWheelerUNC

For #ASCODailyNews, Yousuf Zafar, MD MHS breaks down how technology & data can lower #cancercare costs, reduce acute care utilization, & streamline clinician workflow, allowing the real work of precision care delivery to begin: fal.cn/3sJHs #healthtech #precisionmedicine

So much fun chatting with Bobby Green about how Thyme Care is addressing key challenges in cancer care delivery

Proud of this work and it’s legacy in highlighting the need to identify and address financial burdens faced by patients with cancer - and my enduring friendship with the fantastic Yousuf Zafar, MD MHS Reflections on the Financial Toxicity of Cancer: 10 Years Later academic.oup.com/oncolo/article…

I’m thrilled to join AccessHope as chief medical officer! At AccessHope, our mission is clear: optimize patient outcomes & make cancer care more accessible and equitable for all. I’m deeply honored to join this incredible team, which keeps patients at the heart of every decision